The 131st Annual Meeting (November 15-19, 2003) of APHA |
Sung-Yeon Kang, PhD1, Sherry Deren, PhD1, Jonny Andia, PhD1, Héctor M. Colón, PhD2, and Rafaela R. Robles, EdD2. (1) National Development and Research Institutes, Inc., 71 West 23rd Street, 8th Floor, New York, NY 10010, 212-845-4457, Kang@NDRI.org, (2) Center for Addiction Studies, School of Medicine, Universidad Central del Caribe, PO Box 60327, Bayamón, PR 00960-6032
Objectives: To examine the extent of HIV risk behavior in jail/prison and its relationship with later injection drug use among Puerto Rican drug injectors (IDUs) in New York and Puerto Rico. Methods: Puerto Rican IDUs in New York (N=280) and Puerto Rico (N=192) were reinterviewed in 2002 at 36 months (T2) after the initial interview (T1). Information on their incarceration experiences during the 36 months, including HIV-related risk behaviors, was collected. Results: 76% male, average age 38 (NY); 87% male, average age 33 (PR). Thirty-eight percent of NY sample injected drugs (last 30 days), while approximately two-thirds (70%) of PR injected at T2. During the 36 months prior to T2, 68% of NY and 42% of PR were incarcerated at least once (p<.001). Of those who were incarcerated (N=190, NY; N=81, PR), 5% of NY and 4% of PR engaged in sex (p=ns), and 5% of NY and 54% of PR injected drugs (p<.001) inside jail/prison. During the incarceration, 38% of NY and 1% of PR participated in a drug treatment program (excluded detox). In multivariate analysis, drug injection inside jail/prison was significantly related to drug injection at T2, after adjusting for drug treatment program enrollment in jail/prison and recruitment site (AOR=2.4; CI=1.1, 5.3, p<.05). Conclusions: The findings indicate a need for effective drug treatment programs inside jail/prisons, especially in PR, to reduce HIV-related risk behaviors among drug injectors, during incarceration and after release.
Learning Objectives:
Keywords: Risk Behavior, Inmates
Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.